HYPERKALEMIA
Clinical trials for HYPERKALEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERKALEMIA trials appear
Sign up with your email to follow new studies for HYPERKALEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Potassium pills may shield kidneys from further damage
Disease control OngoingThis study looks at whether taking potassium supplements can slow down kidney function loss in people with moderate-to-severe chronic kidney disease (CKD) who also have high blood pressure. About 532 adults with CKD stage 3b or 4 will receive potassium or a placebo. The main goal…
Matched conditions: HYPERKALEMIA
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated May 26, 2026 11:07 UTC
-
New approach aims to tame dangerous potassium levels in kidney patients
Disease control OngoingThis study looks at whether a standardized treatment plan can help chronic kidney disease patients with high potassium levels (hyperkalemia) better control their condition and optimize their medications. About 1,000 adults with kidney disease and high potassium will follow a guid…
Matched conditions: HYPERKALEMIA
Phase: NA • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Could a smaller insulin dose be just as good for high potassium?
Symptom relief ENROLLING_BY_INVITATIONThis study compares a lower dose of insulin (5 units) with the usual dose (10 units) for treating mild to moderate high potassium in emergency patients. The goal is to see if the lower dose works just as well while causing fewer side effects like low blood sugar. About 50 adults …
Matched conditions: HYPERKALEMIA
Phase: NA • Sponsor: University of Malaya • Aim: Symptom relief
Last updated May 26, 2026 11:04 UTC
-
Study on high potassium and heart meds pulled before starting
Knowledge-focused TerminatedThis study was designed to find out how often high potassium levels lead to changes in heart medications called RAAS inhibitors in emergency room or hospitalized patients. It planned to include adults with high potassium who were taking these drugs. However, the study was withdra…
Matched conditions: HYPERKALEMIA
Sponsor: Portsmouth Hospitals NHS Trust • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC